ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1022

Identification of Shared Genomic Regions in Distantly Related Pairs of Cases with Juvenile Idiopathic Arthritis

Sampath Prahalad1, K. Alaine Broadaway2, John F. Bohnsack3, Ann Dodd2, Aimee O. Hersh4, Sheila T. Angeles-Han1, Se Ryeong Jang1, Marc Sudman5, Susan D. Thompson6, Michael Zwick7, Karen Conneely2 and Michael Epstein2, 1Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, 2Emory University School of Medicine, Atlanta, GA, 3Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT, 4Pediatrics/Rheumatology, University of Utah, Salt Lake City, UT, 5Divison of Rheumatology, Childrens Hospital Med Ctr, Cincinnati, OH, 6Rheumatology Dept, Childrens Hospital Med Ctr, Cincinnati, OH, 7Human Genetics, Emory University School of Medicine, Atlanta, GA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: family studies, genomics, juvenile idiopathic arthritis (JIA) and population studies

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Pediatric Rheumatology - Pathogenesis and Genetic

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Juvenile idiopathic
arthritis (JIA) is a complex genetic trait. While several risk variants have
been identified using genome wide studies, a substantial component of the
genetic risk is unexplained by known variants. We hypothesized that distantly
related JIA cases might share genomic regions that harbor susceptibility
variants.

Methods:   Using probabilistic linking of children with
JIA to the Utah Population Database, we identified distantly related JIA cases
among descendants of founders with 4 or more descendants affected with JIA. We
also identified distantly related controls whose degrees of relationship matched
our cases. We genotyped subjects using Affymetrix 6.0 microarrays, and after
stringent quality control, analyzed them using the Refined IBD program in
Beagle. We identified segments greater than 1000 basepairs shared pairwise
among cases. We
then used GraphIBD to test for single nucleotide polymorphisms (SNPs) that fell
within shared regions of case/case pairs more often control/control or
case/control pairs.

Results: We identified 296 distantly related cases and 300
distantly related controls. In all 194 founders had significantly excessive
number of descendants with JIA (range 4-17).  We genotyped 218 cases and 148
controls, of whom 190 cases and 139 controls met our rigorous quality control inclusion
criteria (excluding individuals with <95% call rate or heterozygosity outliers,
close relatives, and population stratification outliers). Although no SNPs demonstrated
association at genome wide thresholds of significance, many demonstrated
associations at p <1X10-4 (Figure). Of the top 500 SNPs, 120 were
on chr 6, corresponding to a gene EYS, (best p <1.8X10-5) which
is implicated in retinitis pigmentosa, and acute uveitis associated with
ankylosing spondylitis. Variants on chr 20, corresponding to the gene PTPRT,
implicated in rheumatoid arthritis were also associated (p<8 X10-5).
Other regions of interest included NFKRB on chr 11, and two novel
transcripts on chr 4 and 15.

Conclusion: Using a novel approach, we found variants in EYS
and other loci that are shared more often among distantly related JIA case pairs,
although the modest sample size limited our power. Investigating distantly
related JIA case pairs offers a complementary approach to the search for genes
underlying JIA risk. Analysis stratifying subjects by presence of uveitis, and
replication of high priority variants in an independent cohort of JIA are
underway.

Acknowledgements: NIAMS (AR060893), The
Marcus Foundation Inc. 


Disclosure: S. Prahalad, Novartis, 9; K. A. Broadaway, None; J. F. Bohnsack, Novartis Pharmaceutical Corporation, 5; A. Dodd, None; A. O. Hersh, None; S. T. Angeles-Han, None; S. R. Jang, None; M. Sudman, None; S. D. Thompson, None; M. Zwick, None; K. Conneely, None; M. Epstein, None.

To cite this abstract in AMA style:

Prahalad S, Broadaway KA, Bohnsack JF, Dodd A, Hersh AO, Angeles-Han ST, Jang SR, Sudman M, Thompson SD, Zwick M, Conneely K, Epstein M. Identification of Shared Genomic Regions in Distantly Related Pairs of Cases with Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/identification-of-shared-genomic-regions-in-distantly-related-pairs-of-cases-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-shared-genomic-regions-in-distantly-related-pairs-of-cases-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology